Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,456 active trials24 approved drugs58 evidence items
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,550 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03706508 | Pentafecta Outcomes After Robot-assisted Laparoscopic Radical Prostatectomy | unknown | — | 120 | Hospital de Clinicas de Porto AlegreOTHER | 1 | Oct 30, 2018 | clinicaltrials |
| NCT03709485 | Evaluation of Gut Microbiome in Patients With Prostate Cancer | unknown | N/A | 150 | Ziv HospitalOTHER_GOV | 0 | Oct 17, 2018 | clinicaltrials |
| NCT02913859 |
| Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer |
| unknown |
| Phase 2 |
| 60 |
| University Hospital Sestre MilosrdniceOTHER |
| 1 |
| Oct 11, 2018 |
| clinicaltrials |
| NCT03701659 | TUPKRP Combined With MAB Therapy for LUTS/PCa | unknown | N/A | 100 | The Third Xiangya Hospital of Central South UniversityOTHER | 0 | Oct 10, 2018 | clinicaltrials |
| NCT03696186 | Selective Treatment According to Molecular Subtype of Prostate Cancer(STAMP) | unknown | Phase 2 | 300 | Tianjin Medical University Second HospitalOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT03692000 | Designing a Digital Tool to Support Healthy Lifestyle in Men With Prostate Cancer(Emil2) | unknown | — | 55 | Danish Cancer SocietyOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT03177551 | Predictive Nomogram of CRPC(CRPC-PN) | unknown | — | 300 | Tianjin Medical University Second HospitalOTHER | 1 | Oct 1, 2018 | clinicaltrials |
| NCT03687918 | External Validation of Prostate MRI QCAD/Lyon(DIJON-CAD) | unknown | — | 80 | Hospices Civils de LyonOTHER | 1 | Sep 27, 2018 | clinicaltrials |
| NCT03677414 | Analysis of Androgene Receptors Axis and DNA Damage Repair Genes in Patients With Prostate Cancer | unknown | — | 59 | Medical University of GrazOTHER | 1 | Sep 19, 2018 | clinicaltrials |
| NCT02058680 | Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients(PSA) | unknown | Phase 1 | 48 | OncBioMune PharmaceuticalsOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT03662958 | Comparison of a Novel Leuprolide With Market Leuprolide | unknown | N/A | 48 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | Sep 10, 2018 | clinicaltrials |
| NCT03658525 | Prostate Radiotherapy Integrated With Simultaneous MRI (The PRISM Study)(PRISM) | unknown | N/A | 30 | Royal Marsden NHS Foundation TrustOTHER | 1 | Sep 7, 2018 | clinicaltrials |
| NCT02295449 | Quantitative Prostate Cancer Contrast-enhanced Ultrasound(SONOCAP) | unknown | N/A | 130 | Hospices Civils de LyonOTHER | 1 | Aug 31, 2018 | clinicaltrials |
| NCT03650946 | Clinical Application of 68Ga-PSMA PET in Prostate Cancer | unknown | — | 150 | National Taiwan University HospitalOTHER | 1 | Aug 29, 2018 | clinicaltrials |
| NCT03082274 | Prospective Validation of Prostate Biomarkers for Repeat Biopsy(PRIORITY) | unknown | — | 1,000 | MDx HealthINDUSTRY | 1 | Aug 17, 2018 | clinicaltrials |
| NCT03632980 | Dynamic Focusing Evaluation for Prostate Cancer Treatment(FOC/DYN) | unknown | N/A | 180 | EDAP TMS S.A.INDUSTRY | 1 | Aug 16, 2018 | clinicaltrials |
| NCT03623425 | Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancer(TEPGALCHOL) | unknown | Phase 3 | 46 | Central Hospital, Nancy, FranceOTHER | 1 | Aug 9, 2018 | clinicaltrials |
| NCT02525068 | A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC(RE-AKT) | unknown | Phase 2 | 136 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 8, 2018 | clinicaltrials |
| NCT03413007 | Correlation Between iXip and Final Pathology Specimen From Radical Prostatectomy: a Multicenter Prospective Trial | unknown | — | 300 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Jul 19, 2018 | clinicaltrials |
| NCT00407875 | Intensity Modulated Versus Interstitial - Radiation Therapy | unknown | N/A | 50 | British Columbia Cancer AgencyOTHER | 1 | Jul 13, 2018 | clinicaltrials |
| NCT02940977 | Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique | unknown | — | 120 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT03580239 | Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency | unknown | Phase 3 | 120 | Tianjin Medical University Second HospitalOTHER | 1 | Jul 9, 2018 | clinicaltrials |
| NCT03238066 | Salvage Brachytherapy and Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following Radiation Therapy(Prostata-BT-HT) | unknown | N/A | 77 | University of Erlangen-Nürnberg Medical SchoolOTHER | 2 | Jun 7, 2018 | clinicaltrials |
| NCT03533998 | Biomarkers in Prostate Cancer Treated With SRP Following Failure of FAT | unknown | — | 30 | Institut Mutualiste MontsourisOTHER | 1 | May 23, 2018 | clinicaltrials |
| NCT03516045 | A Study of 18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate Cancer | unknown | Phase 1 / Phase 2 | 65 | Xiangya Hospital of Central South UniversityOTHER | 1 | May 17, 2018 | clinicaltrials |
| NCT03525652 | Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment | unknown | Phase 1 / Phase 2 | 30 | The First Affiliated Hospital of Guangdong Pharmaceutical UniversityOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03507595 | Evaluation of the Metastasis and Recurrence of Prostate Cancer | unknown | — | 400 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT02294903 | Focal Prostate Radiofrequency Ablation(ProRAFT) | unknown | N/A | 20 | Trod Medical N.V.INDUSTRY | 1 | Apr 24, 2018 | clinicaltrials |
| NCT01890096 | A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer | unknown | Phase 2 | 174 | Sunnybrook Health Sciences CentreOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT03496142 | Perineal Versus Rectal Approach for Prostate Biopsy to Prevent Iatrogenic Infections(PRAPI) | unknown | N/A | 340 | Institut Mutualiste MontsourisOTHER | 1 | Apr 12, 2018 | clinicaltrials |
| NCT03488706 | Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level | unknown | — | 500 | CellMaxLifeINDUSTRY | 1 | Apr 5, 2018 | clinicaltrials |
| NCT02313298 | Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer | unknown | Phase 2 | 80 | National Cancer Centre, SingaporeOTHER | 1 | Mar 29, 2018 | clinicaltrials |
| NCT03418207 | The Accuracy of Modified TTMB in the Spatial Distribution of Prostate Cancer | unknown | N/A | 50 | Subei People's Hospital of Jiangsu ProvinceOTHER | 1 | Mar 29, 2018 | clinicaltrials |
| NCT03479359 | Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship | unknown | — | 700 | Changhai HospitalOTHER | 1 | Mar 27, 2018 | clinicaltrials |
| NCT03439397 | RCT of Ballon Technique VS Selective Ophthalmic Artery Infusion For the Retinoblastoma Patients | unknown | N/A | 496 | Guangzhou Women and Children's Medical CenterOTHER | 0 | Mar 1, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT02936258 | PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation Procedures(PRECISE) | unknown | N/A | 450 | Canadian Urology Research ConsortiumOTHER | 1 | Feb 22, 2018 | clinicaltrials |
| NCT03428087 | Prostate Impendance Test Project(PROSIT) | unknown | — | 100 | University of PisaOTHER | 1 | Feb 19, 2018 | clinicaltrials |
| NCT03425240 | Intra-operative Neuromodulation of the Pelvic Plexus | unknown | N/A | 20 | Laikο General Hospital, AthensOTHER | 1 | Feb 8, 2018 | clinicaltrials |
| NCT03406169 | Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy | unknown | Phase 3 | 180 | Brooke Army Medical CenterFED | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02322931 | C-arm Cone-beam CT in Prostate Brachytherapy(C-arm) | unknown | N/A | 35 | British Columbia Cancer AgencyOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT03196388 | Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer(ENZART) | unknown | Phase 2 | 70 | Fundación Canaria Instituto de Investigación Sanitaria de CanariasOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT03403595 | 177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer | unknown | Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT03356912 | CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy | unknown | Phase 2 | 220 | Consorzio OncotechOTHER | 1 | Dec 14, 2017 | clinicaltrials |
| NCT03356444 | Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the Prostate | unknown | Phase 2 | 140 | West China HospitalOTHER | 0 | Nov 29, 2017 | clinicaltrials |
| NCT03351088 | Outcomes From a RCT Comparing Preventive Versus Delayed Ligation of DVC During Robot-assisted Radical Prostatectomy | unknown | N/A | 226 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Nov 22, 2017 | clinicaltrials |
| NCT03344822 | Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients(TePSMAG-68) | unknown | Phase 2 / Phase 3 | 33 | Central Hospital, Nancy, FranceOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT03098160 | Immunotherapy Study of Evofosfamide in Combination With Ipilimumab | unknown | Phase 1 | 69 | Threshold PharmaceuticalsINDUSTRY | 1 | Oct 30, 2017 | clinicaltrials |
| NCT03313726 | The Effect of ADT on PSMA-PET.(ADTPSMA) | unknown | N/A | 30 | Turku University HospitalOTHER_GOV | 1 | Oct 18, 2017 | clinicaltrials |
| NCT02724618 | Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT) | unknown | Phase 2 | 64 | Shahid Beheshti University of Medical SciencesOTHER | 1 | Oct 12, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Oct 30, 2018source: clinicaltrials